drugset / Trial / NCT05943223

Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)

NCT05943223

Phase 2 Completed 16 enrolled McMaster Children's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is an internal pilot for a multicenter, blinded randomized controlled trial. The purpose of the multicenter trial is to determine whether post-operative piperacillin/tazobactam is more effective than ceftriaxone and metronidazole for children treated with laparoscopic appendectomy for perforated appendicitis. We plan to conduct an internal pilot study to determine whether a blinded multicenter randomized controlled trial is feasible.

Timeline

Start
2024-09-09
Primary completion
2025-07-16
Completion
2025-10-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftriaxone Other / unclassified 50 mg/kg Intravenous
Comparator Metronidazole Small molecule 10 mg/kg Intravenous
Subject Piperacillin/tazobactam Unknown 100 mg/kg Intravenous

Indications